Medidata Solutions to Present at Key Events in September

FOR IMMEDIATE RELEASE
 

Clinical Trial Technology Leaders to Share Expertise on
Post-Approval Studies, Trial Budgeting and Clinical System Integrations

NEW YORK, N.Y. – September 8, 2010 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that members of its management team will deliver the following presentations at key events in September:
World Drug Safety Congress Europe 2010
September 14–17, London, UK
Presentation: “The Use of Technology in Observational Research”
Speaker: Patrick Chassaigne, Director, Late Phase Solutions
Date & Time: Tuesday, September 14, 12:30 p.m. BST

Making and fulfilling the right safety procedures is vitally important in today’s pharmaceutical industry and imperative to ensuring the successful long-term future of a drug. The 4th annual World Drug Safety Congress Europe brings together top pharmaceutical, biotechnology and regulatory representatives in a discussion forum that addresses key issues of the industry. To learn more, please visit: World Drug Safety Congress Europe.

CDISC Interchange China
September 13–17, Shanghai, China
Presentation: “Integration of Electronic Data Capture (EDC) and Interactive Voice Response (IVR) Randomization Systems Using ODM, Vendor Extensions and Web Services”
Speaker: Andrew Newbigging, Vice President, Integrations Development
Date & Time: Wednesday, September 15, 3:30 p.m. CST

CDISC Interchange China discusses CDISC standards and initiatives. The aim of the Interchange is to provide a discussion forum where the CDISC leaders and experts from countries around the world can share their experience of the latest CDISC developments and the practical applications for the process of drug development. Exhibitors will also demonstrate how CDISC standards can be adopted in daily work. To learn more, please visit: CDISC Interchange China.

2nd Annual Improved Clinical Development: Budgeting, Forecasting & Cost Management
September 22–23, London, UK
Presentation: “Optimising the Site Budget in a Diverse and Financially Rocky World”
Speaker: Jessica Dolfi, Business Consultant
Date & Time: Wednesday, September 22, 12:20 p.m. BST

This annual event is Europe's only event focused on finance for clinical trials. The conference will provide attendees with insight into the current techniques and methods available to ensure that clinical trial costs are kept to a minimum. The event will also explore how to make the most of clinical trial resources in the current financial climate and how to develop a successful budget plan by considering key methods for improving the forecast of clinical trials. To learn more, please visit: Improved Clinical Development.

2010 SoCRA Annual Conference
September 24–26, Dallas, TX
Presentation: “Meaningful Metrics that Objectively Demonstrate Value to Sponsors”
Speaker: Sondra Pepe, Associate Product Manager
Date & Time: Friday, September 24, 2:15 to 3:00 p.m. CT

Presentation: “Considerations for Clinical Trial Budgeting in Light of Physician Payment Reporting Legislation”
Speaker: Sondra Pepe, Associate Product Manager
Date & Time: Saturday, September 25, 2:15 to 3:00 p.m. CT

The Society of Clinical Research Associates, Inc. (SoCRA) is a non-profit, professional organization dedicated to the continuing education and development of clinical research professionals. The 19th Annual Conference is part of their mission to provide training, continuing education and an internationally recognized certification program that promotes quality clinical research to protect the welfare of research participants and improve global health. To learn more, please visit: SoCRA Annual Conference.

CBI 13th Registries & Post-Approval Studies Congress
September 28–30, Princeton, NJ
Presentation: “Practical Approaches for Cost-Effective Global Post-Approval Studies”
Speaker: Patrick Chassaigne, Director, Late Phase Solutions
Date & Time: Wednesday, September 29, 4:30 p.m. ET

CBI’s annual forum convenes thousands of industry leaders to network and develop strategies for optimizing late phase research, which is profoundly affected by the substantial changes in the bio/pharmaceutical industry. The congress will explore how to meet the needs of diverse external constituencies with multi-faceted registries, select the right sites and patients, deal with missing or inconsistent data—and solutions for overcoming them. To learn more, please visit: Registries and Post-Approval Studies Congress.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical trials. For over 10 years, Medidata has consistently brought next-generation innovation to the life science industry to lower the total cost of clinical development through informed trial planning and management, optimized clinical processes and platform interoperability. Medidata’s advanced solutions address key functions throughout the clinical development process including protocol development (Medidata Designer®), trial planning and management (Medidata Grants Manager®, Medidata CRO Contractor®), user and learning management (iMedidata™), randomization and trial supply management (Medidata Balance™), monitoring (Medidata Rave Monitor, Medidata Rave Targeted SDV), Serious Adverse Events capture (Medidata Rave Safety Gateway) and clinical data capture, management and reporting (Medidata Rave®). Our diverse customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.

Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com